Ginkgo Bioworks (DNA) News Today $10.86 -0.58 (-5.03%) Closing price 03:59 PM EasternExtended Trading$10.96 +0.11 (+0.97%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput labFebruary 21 at 9:00 AM | prnewswire.comGinkgo Bioworks partners with HaDEA in up to EUR 24M projectFebruary 21 at 4:09 AM | markets.businessinsider.comGinkgo Bioworks (DNA) Expected to Announce Quarterly Earnings on TuesdayFebruary 21 at 2:07 AM | americanbankingnews.comGinkgo Bioworks (DNA) to Release Earnings on TuesdayGinkgo Bioworks (NYSE:DNA) will be releasing earnings after the market closes on Tuesday, February 25, Financial Modeling Prep reports.February 21 at 2:06 AM | marketbeat.comGinkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of CareFebruary 20 at 8:01 AM | prnewswire.comGinkgo Bioworks (NYSE:DNA) Shares Down 6.3% - Time to Sell?Ginkgo Bioworks (NYSE:DNA) Stock Price Down 6.3% - Should You Sell?February 19 at 11:59 PM | marketbeat.comGinkgo Bioworks Holdings, Inc. (NYSE:DNA) Short Interest Up 5.4% in JanuaryGinkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) saw a significant increase in short interest in January. As of January 31st, there was short interest totalling 8,250,000 shares, an increase of 5.4% from the January 15th total of 7,830,000 shares. Based on an average trading volume of 1,490,000 shares, the days-to-cover ratio is currently 5.5 days. Currently, 22.6% of the company's shares are short sold.February 18 at 5:34 PM | marketbeat.comGinkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results PresentationFebruary 18 at 8:00 AM | prnewswire.comGinkgo Bioworks (NYSE:DNA) Trading 8.8% Higher - Here's WhyGinkgo Bioworks (NYSE:DNA) Trading Up 8.8% - Time to Buy?February 15, 2025 | marketbeat.comAnalyzing ZIVO Bioscience (NASDAQ:ZIVO) and Ginkgo Bioworks (NYSE:DNA)February 15, 2025 | americanbankingnews.comDNA from Fiserv Selected by Third Federal as Part of its Digital TransformationFebruary 14, 2025 | businesswire.comGinkgo Bioworks Holdings, Inc. (DNA) Dips More Than Broader Market: What You Should KnowFebruary 13, 2025 | msn.comGinkgo Bioworks (NYSE:DNA) Trading Down 5.4% - What's Next?Ginkgo Bioworks (NYSE:DNA) Stock Price Down 5.4% - Here's WhyFebruary 12, 2025 | marketbeat.comSG Americas Securities LLC Takes $199,000 Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)SG Americas Securities LLC acquired a new stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 20,295 shares of the company's stock, valued at approxFebruary 9, 2025 | marketbeat.comForbes J M & Co. LLP Has $6.89 Million Stock Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)Forbes J M & Co. LLP increased its position in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 461.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 701,732 shares of the company's stock after aFebruary 8, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Stock Price Up 7.9% - What's Next?Ginkgo Bioworks (NYSE:DNA) Shares Up 7.9% - Time to Buy?February 7, 2025 | marketbeat.comGinkgo Bioworks CFO Dmytruk sells $9,947 in stockFebruary 6, 2025 | msn.comGinkgo Bioworks' chief accounting officer sells $4,933 in stockFebruary 6, 2025 | msn.comGinkgo Bioworks (NYSE:DNA) Stock Price Down 6.8% - What's Next?Ginkgo Bioworks (NYSE:DNA) Shares Down 6.8% - Here's What HappenedFebruary 6, 2025 | marketbeat.comGinkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference SeriesFebruary 6, 2025 | prnewswire.comGinkgo Bioworks (NYSE:DNA) Stock Price Up 7.9% - Here's WhyGinkgo Bioworks (NYSE:DNA) Shares Up 7.9% - Time to Buy?February 5, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Shares Gap Down - Time to Sell?Ginkgo Bioworks (NYSE:DNA) Shares Gap Down - Here's WhyFebruary 3, 2025 | marketbeat.comGinkgo Bioworks Holdings, Inc. (NYSE:DNA) Position Trimmed by JPMorgan Chase & Co.JPMorgan Chase & Co. lowered its stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 97.4% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 15,305 shares of the company's stock after selling 576,747 shares during thFebruary 3, 2025 | marketbeat.comPFG Investments LLC Lowers Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)PFG Investments LLC cut its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 90.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 18,900 shares of the company's stock after selling 170February 2, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Trading Down 6.3% - Time to Sell?Ginkgo Bioworks (NYSE:DNA) Trading Down 6.3% - Here's What HappenedJanuary 31, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Trading 9.7% Higher - What's Next?Ginkgo Bioworks (NYSE:DNA) Shares Up 9.7% - Time to Buy?January 30, 2025 | marketbeat.comGinkgo Bioworks Holdings, Inc. (DNA) Stock Moves -0.24%: What You Should KnowJanuary 30, 2025 | msn.comGinkgo Bioworks: Declining Core Revenue And High Cash Burn Echo Amyris' PathJanuary 30, 2025 | seekingalpha.comExchange Traded Concepts LLC Has $1.88 Million Stock Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)Exchange Traded Concepts LLC lowered its holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 47.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 191,274 shares of the company's stock after selling 175,January 27, 2025 | marketbeat.comGinkgo Bioworks price target raised to $16 from $10 at TD CowenJanuary 25, 2025 | markets.businessinsider.comStargate Project’s healthcare winners: AI-led biotechs and MetagenomiJanuary 25, 2025 | msn.comBarclays PLC Sells 125,931 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)Barclays PLC decreased its position in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 91.3% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,942 shares of the company's stock after selling 1January 24, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Shares Gap Down - Should You Sell?Ginkgo Bioworks (NYSE:DNA) Shares Gap Down - Time to Sell?January 23, 2025 | marketbeat.comGinkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC)January 23, 2025 | prnewswire.comGinkgo Bioworks (NYSE:DNA) Trading 6.4% Higher - Should You Buy?Ginkgo Bioworks (NYSE:DNA) Stock Price Up 6.4% - Here's WhyJanuary 22, 2025 | marketbeat.comAldevron Unveils Next-Generation Alchemyâ„¢ Cell-Free DNA Technology for Research Grade ApplicationsJanuary 21, 2025 | businesswire.comGinkgo Bioworks (NYSE:DNA) Shares Gap Up - Here's What HappenedGinkgo Bioworks (NYSE:DNA) Shares Gap Up - What's Next?January 17, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Trading 9.1% Higher - Still a Buy?Ginkgo Bioworks (NYSE:DNA) Trading Up 9.1% - Still a Buy?January 16, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Shares Gap Up - Should You Buy?Ginkgo Bioworks (NYSE:DNA) Shares Gap Up - Here's WhyJanuary 15, 2025 | marketbeat.comTD Cowen Remains a Buy on Ginkgo Bioworks Holdings (DNA)January 15, 2025 | markets.businessinsider.comGinkgo Bioworks, Universal Cells form research collaborationJanuary 14, 2025 | markets.businessinsider.comGinkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid TumorsJanuary 13, 2025 | prnewswire.comRegeneron Collaborates with Truveta and Leading American Health Systems to Massively Extend its DNA Sequence-Linked Healthcare Database to Further Advance Scientific Innovation and Healthcare DeliveryJanuary 13, 2025 | globenewswire.comGinkgo Bioworks (NYSE:DNA) Trading Down 9.1% - What's Next?Ginkgo Bioworks (NYSE:DNA) Shares Down 9.1% - What's Next?January 10, 2025 | marketbeat.comRapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and GenomicsJanuary 9, 2025 | globenewswire.comGinkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 9, 2025 | prnewswire.comBarclays PLC Has $98,000 Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)Barclays PLC trimmed its position in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 91.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,942 shares of the company's stock after selJanuary 9, 2025 | marketbeat.comGinkgo Bioworks (NYSE:DNA) Trading 6.5% Higher - Here's WhyGinkgo Bioworks (NYSE:DNA) Trading Up 6.5% - Time to Buy?January 7, 2025 | marketbeat.comGinkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by Geode Capital Management LLCGeode Capital Management LLC reduced its holdings in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 97.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 416,631 shares of the compJanuary 7, 2025 | marketbeat.comGinkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Sold by State Street CorpState Street Corp cut its stake in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Free Report) by 97.9% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 216,021 shares of the company's stock after selling 9,876,644 shares during the pJanuary 2, 2025 | marketbeat.com Get Ginkgo Bioworks News Delivered to You Automatically Sign up to receive the latest news and ratings for DNA and its competitors with MarketBeat's FREE daily newsletter. Email Address DNA Media Mentions By Week DNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DNA News Sentiment▼0.360.60▲Average Medical News Sentiment DNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DNA Articles This Week▼107▲DNA Articles Average Week Get Ginkgo Bioworks News Delivered to You Automatically Sign up to receive the latest news and ratings for DNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACADIA Pharmaceuticals News Today Crinetics Pharmaceuticals News Today Zai Lab News Today Denali Therapeutics News Today Xenon Pharmaceuticals News Today MorphoSys News Today Twist Bioscience News Today Vericel News Today Catalyst Pharmaceuticals News Today MoonLake Immunotherapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:DNA) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ginkgo Bioworks Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ginkgo Bioworks With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DNA Stock Alerts